Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug;185(2):242-243.
doi: 10.1111/bjd.20430. Epub 2021 May 25.

Tildrakizumab: interpreting the data

C G Purvis  1 , V K Emmerich  1 , S R Feldman  1   2   3   4
Affiliations
Comment

Tildrakizumab: interpreting the data

C G Purvis et al. Br J Dermatol. 2021 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Warren RB, Hansen JB, Reich K et al. Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE-2 and -3. J Eur Acad Dermatol Venereol 2021; 35:450-7.
    1. Thaçi D, Piaserico S, Warren RB et al. Five-year efficacy and safety of tildrakizumab in patients with moderate to severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2). Br J Dermatol 2021; https://doi.org/10.1111/bjd.19866.
    1. Langley RGB, Reich K, Papavassilis C et al. Methods for imputing missing efficacy data in clinical trials of biologic psoriasis therapies: implications for interpretations of trial results. J Drugs Dermatol 2017; 16:734-41.
    1. Papp KA, Fonjallaz P, Casset-Semanaz F et al. Analytical approaches to reporting long-term clinical trial data. Curr Med Res Opin 2008; 24:2001-8.
    1. Sterne JAC, White IR, Carlin JB et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009; 338:b2393.

Substances